share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 22 07:02
Summary by Futu AI
AbbVie Inc. officer, Azita Saleki-Gerhardt, is set to sell 52,870 shares of the company's common stock on February 21, 2024, according to a recent filing. The shares, valued at approximately $9,184,486.84, were acquired on the same date through a stock option exercise as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Saleki-Gerhardt in the past three months.
AbbVie Inc. officer, Azita Saleki-Gerhardt, is set to sell 52,870 shares of the company's common stock on February 21, 2024, according to a recent filing. The shares, valued at approximately $9,184,486.84, were acquired on the same date through a stock option exercise as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Saleki-Gerhardt in the past three months.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.